News Center - Luye Life Sciences

News Center

First in China: BLA for Boan’s Dulaglutide Injection Accepted

2024-05-28 MORE>
Boan’s Boluojia® (Denosumab) Approved for Marketing in China

2024-05-27 MORE>
Boan Biotech Announces 2023 Financial Results

2024-03-26 MORE>
Luye Pharma’s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

2024-03-07 MORE>
Boan Biotech Obtains ANVISA GMP Certification

2024-01-18 MORE>
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA

2023-12-28 MORE>

Total:143 / Page:24 First Prev 3 4 5 6 7 Next Last

鲁ICP备05023892号-5 LUYE All Rights Reserved Privacy policy Terms of use

TOP